News
NXL
1.650
-2.37%
-0.040
Nexalin Technology Has Received A Notice Of Allowance For Its U.S. Patent Application 18/342,590 Titled "Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) Method For Alzheimers And Dementia"
Benzinga · 2d ago
Weekly Report: what happened at NXL last week (0422-0426)?
Weekly Report · 4d ago
Weekly Report: what happened at NXL last week (0415-0419)?
Weekly Report · 04/22 11:12
Predictive Oncology, BIMI Holdings, IMAC Holdings among healthcare movers
Seeking Alpha · 04/19 14:00
LI, VERU and MRIN among pre-market losers
Seeking Alpha · 04/19 12:16
12 Health Care Stocks Moving In Friday's Pre-Market Session
Chromocell Therapeutics (AMEX:CHRO) stock increased by 21.6% to $1.49 during Friday's pre-market session. Kineta stock moved upwards by 16.62% and Erasca stock rose 13.73%. Nexalin Technology (NASDAQ:NXL) stock fell 18.4% during the day.
Benzinga · 04/19 12:08
BUZZ-U.S. STOCKS ON THE MOVE-Paramount Global, SES AI, Zhongchao
U.S. Stock index futures slip on Friday as investors turn risk-averse. Netflix falls in premarket trade after company forecast current-quarter revenue below estimates. Dow e-minis down 0.17% while Nasdaq 100 futures also down. Paramount Global, SES AI and Zhongchao are among the top percentage gainers.
Reuters · 04/19 12:03
Lexaria Bioscience, Biosig Technologies, BIMI Holdings among healthcare movers
Seeking Alpha · 04/17 14:00
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Sk Skillsoft Corp. Shares dipped 26.7% to $6.74 on Tuesday. The company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates. WiSA Technologies, Inc. Shares jumped 85% after the company announced a licensing agreement with an HDTV/PTV brand.
Benzinga · 04/16 18:17
JAGX, BSGM and SXTC among mid-day movers
Seeking Alpha · 04/16 16:40
12 Health Care Stocks Moving In Tuesday's Intraday Session
Palisade Bio (NASDAQ:PALI) stock increased by 65.1% to $6.87 during Tuesday's regular session. China SXT Pharmaceuticals and Intra-Cellular Therapies were among the gainers. Calidi Biotherapeutics (AMEX:CLDI) shares decreased by 58.5% during the session.
Benzinga · 04/16 16:31
Nexalin Technology files to offer common stock worth $5.65M
Nexalin Technology files to offer common stock worth $5.65M. Nexalin Technology, Inc. Filed a prospectus related to the proposed sale of its common stock. This prospectus is not an offer to sell these securities. The company's stock is listed on the Nasdaq.
Seeking Alpha · 04/16 15:30
Palisade Bio, Marinus Pharmaceuticals, Poseida Therapeutics among healthcare movers
Healthcare On the Move: Palisade Bio, Marinus Pharmaceuticals, Poseida Therapeutics among healthcare movers. S&P 500 Health Care Sector +0.08% to 1617.11. Health Care Equipment & Services among healthcare mover.
Seeking Alpha · 04/16 14:00
Weekly Report: what happened at NXL last week (0408-0412)?
Weekly Report · 04/15 11:04
Nexalin Technology CEO Provides Letter to Shareholders
Nexalin is developing a headset to treat insomnia, depression, anxiety and other mental health conditions. The company recently announced positive results from a clinical study. Nexalin is targeting the U.S. Government and military and government advisory board to help advance the company's technology. CEO says the company is ahead of schedule and under budget.
Benzinga · 04/10 12:36
Molecular Templates, Acorda Therapeutics, MyMD Pharmaceuticals among healthcare movers
Molecular Templates, Acorda Therapeutics, MyMD Pharmaceuticals among healthcare movers. S&P 500 Health Care Sector +0.11% to 1666.38. Pharmaceuticals, Biotechnology & Life Science contributes 58% to index.
Seeking Alpha · 04/09 14:00
BUZZ-U.S. STOCKS ON THE MOVE-Ocugen, Model N, Fastly
Futures tracking Wall Street's main indexes were largely muted on Monday. Treasury yields rose on rising bets that the U.S. Federal Reserve could delay interest-rate cuts this year. Dow e-minis were up 0.13% in early trading. Ocugen up 9.8% on FDA approval of gene therapy for Parkinson's disease.
Reuters · 04/08 13:50
PERI, ITRM and CADL among pre-market losers
On the Move PERI, ITRM and CADL among pre-market losers. Perion Network Ltd. (PERI) announces preliminary Q1 2024 financial results. ZOOZ Power Ltd. Is one of the companies to report positive results for first quarter of 2024.
Seeking Alpha · 04/08 12:23
BUZZ-U.S. STOCKS ON THE MOVE- Ducommun, Tesla, Take-Two
U.S. Stock index futures were flat on Monday as Treasury yields rose. Dow e-minis down 0.01%. Ducommun, Tesla, Take-Two are among the top percentage gainers on the NYSE. Tesla up 2.2% after Musk to unveil 'Robotaxi' on August 8.
Reuters · 04/08 12:17
Weekly Report: what happened at NXL last week (0401-0405)?
Weekly Report · 04/08 11:09
More
Webull provides a variety of real-time NXL stock news. You can receive the latest news about Nexalin Tech through multiple platforms. This information may help you make smarter investment decisions.
About NXL
Nexalin Technology, Inc. is engaged in designing and developing neurostimulation products for the mental health epidemic. The Company has developed an easy-to-administer medical device (Generation 1 or Gen-1) that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit a waveform at 4 milliamps during treatment. It also has designed and developed a new advanced waveform technology to be emitted at 15 milliamps through new and improved medical devices referred to as (Generation 2 or Gen-2) and (Generation 3 or Gen-3). Gen-2 is a clinical use device with a modern enclosure to emit the new 15 milliamp advanced waveform. Gen-3 is a new patient headset that will be prescribed by licensed medical professionals in a virtual clinic setting like existing telehealth platforms. Its products are non-invasive and undetectable to the human body.